<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ten out of 31 cases of severe <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>-resistant <z:hpo ids='HP_0000554'>uveitis</z:hpo> showed a good clinical response to systemic <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Cases of <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's syndrome</z:e>, <z:e sem="disease" ids="C0029077" disease_type="Disease or Syndrome" abbrv="">sympathetic ophthalmia</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0010543" disease_type="Disease or Syndrome" abbrv="">cyclitis</z:e>, and rheumatoid <z:e sem="disease" ids="C0521677" disease_type="Disease or Syndrome" abbrv="">sclerouveitis</z:e> seem to be in the most favorable categories to be considered for cytotoxic-immunosuppressive therapy </plain></SENT>
</text></document>